Title |
Stage migration due to introduction of the sentinel node procedure: a population-based study
|
---|---|
Published in |
Breast Cancer Research and Treatment, February 2008
|
DOI | 10.1007/s10549-008-9913-8 |
Pubmed ID | |
Authors |
A. J. G. Maaskant, L. V. van de Poll-Franse, A. C. Voogd, J. W. W. Coebergh, M. C. B. J. E. Tutein Nolthenius-Puylaert, G. A. P. Nieuwenhuijzen |
Abstract |
Introduction of sentinel node biopsy (SNB) as an axillary staging procedure in breast cancer patients could have led to upstaging as well as downstaging of their disease. Intensified pathological processing could have led to upstaging due to presence of micrometastases, whereas the described false negative rate of 5% could be a cause of downstaging. We investigated whether or not the introduction of the sentinel node procedure has changed the incidence of axillary nodal micrometastases and induced stage migration on a population based level. |
Mendeley readers
The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 2% |
France | 1 | 2% |
Unknown | 53 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 7% |
Professor > Associate Professor | 3 | 5% |
Student > Bachelor | 3 | 5% |
Student > Doctoral Student | 2 | 4% |
Student > Master | 2 | 4% |
Other | 1 | 2% |
Unknown | 40 | 73% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 18% |
Agricultural and Biological Sciences | 2 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Unknown | 42 | 76% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2012.
All research outputs
#1,687,203
of 22,687,320 outputs
Outputs from Breast Cancer Research and Treatment
#223
of 4,618 outputs
Outputs of similar age
#6,154
of 156,020 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#1
of 26 outputs
Altmetric has tracked 22,687,320 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,618 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,020 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.